• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. SIMON NITINOL FILTER SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. SIMON NITINOL FILTER SYSTEM; VENA CAVA FILTER Back to Search Results
Catalog Number 2220J
Device Problems Malposition of Device (2616); Patient-Device Incompatibility (2682); Patient Device Interaction Problem (4001)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
The lot number was provided for 1 out of 2 reported malfunctions, therefore, lot history review was performed.The product catalog number for one malfunction was updated as unknown snf.The devices were not returned to the manufacturer for evaluation/inspection; however medical records were provided and reviewed for both malfunctions.Therefore, the investigation for the two reported malfunctions were confirmed for alleged perforation of the inferior vena cava and filter tilt.Based on the available information, the definitive root cause is unknown.The devices are labeled for single use.
 
Event Description
This report summarizes two malfunctions.A review of the reported information indicates that model 2220j vena cava filter allegedly perforated and tilted.The information was received from various source.Both the malfunctions were involved patients with no reported consequences.Of the reported malfunctions, two female patients ages were ranged from 52 to 67 years old; however, the weights were not provided.
 
Manufacturer Narrative
H10: the lot number was provided for 1 out of 2 reported malfunctions , therefore, lot history review was performed.The devices were not returned to the manufacturer for evaluation/inspection; however medical records were provided and reviewed for both malfunctions.For 1 of the 2 malfunctions, the investigation is confirmed for perforation and tilt.The remaining one malfunction was identified for perforation, tilt and migration based on medical record review.Based on the available information, the definitive root cause is unknown.The devices are labeled for single use.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
This report summarizes two malfunctions.A review of the reported information indicates that model 2220j vena cava filter allegedly perforation and tilt.The information was received from various source.Both the malfunctions were involved patients with no reported consequences.Of the reported malfunctions, two female patients ages were ranged from 52 to 67 years old; however, the weights were not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIMON NITINOL FILTER SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key11224326
MDR Text Key228843599
Report Number2020394-2021-80122
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 03/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue Number2220J
Device Lot NumberGFQL4085,UNKNOWN
Initial Date Manufacturer Received 12/31/2020
Initial Date FDA Received01/25/2021
Supplement Dates Manufacturer Received03/30/2021
Supplement Dates FDA Received03/31/2021
Patient Sequence Number1
-
-